Cytori Therapeutics Inc Current Ratio 2006-2020 | PSTV

Cytori Therapeutics Inc current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Cytori Therapeutics Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-09-30 $0.01B $0.01B 1.03
2020-06-30 $0.01B $0.01B 1.10
2020-03-31 $0.02B $0.02B 1.18
2019-12-31 $0.02B $0.01B 1.37
2019-09-30 $0.02B $0.01B 1.54
2019-06-30 $0.01B $0.01B 0.38
2019-03-31 $0.01B $0.02B 0.46
2018-12-31 $0.01B $0.02B 0.55
2018-09-30 $0.01B $0.02B 0.61
2018-06-30 $0.01B $0.02B 0.42
2018-03-31 $0.01B $0.02B 0.60
2017-12-31 $0.02B $0.02B 0.81
2017-09-30 $0.01B $0.02B 0.54
2017-06-30 $0.02B $0.01B 1.18
2017-03-31 $0.01B $0.01B 0.94
2016-12-31 $0.02B $0.01B 1.50
2016-09-30 $0.02B $0.01B 1.93
2016-06-30 $0.03B $0.01B 2.65
2016-03-31 $0.02B $0.01B 1.71
2015-12-31 $0.02B $0.01B 2.52
2015-09-30 $0.03B $0.01B 2.75
2015-06-30 $0.03B $0.01B 3.22
2015-03-31 $0.02B $0.02B 1.06
2014-12-31 $0.02B $0.02B 1.36
2014-09-30 $0.02B $0.01B 1.01
2014-06-30 $0.02B $0.02B 1.23
2014-03-31 $0.02B $0.02B 1.49
2013-12-31 $0.03B $0.02B 1.65
2013-09-30 $0.02B $0.01B 1.43
2013-06-30 $0.02B $0.01B 2.77
2013-03-31 $0.02B $0.02B 1.45
2012-12-31 $0.03B $0.02B 1.93
2012-09-30 $0.02B $0.02B 1.54
2012-06-30 $0.03B $0.01B 2.58
2012-03-31 $0.04B $0.01B 3.68
2011-12-31 $0.04B $0.01B 5.54
2011-09-30 $0.05B $0.01B 7.39
2011-06-30 $0.04B $0.02B 2.59
2011-03-31 $0.05B $0.02B 3.34
2010-12-31 $0.06B $0.01B 4.46
2010-09-30 $0.04B $0.01B 3.79
2010-06-30 $0.04B $0.01B 6.06
2010-03-31 $0.03B $0.01B 4.07
2009-12-31 $0.02B $0.01B 2.21
2009-09-30 $0.02B $0.01B 2.71
2009-06-30 $0.02B $0.01B 2.83
2009-03-31 $0.02B $0.01B 2.86
2008-12-31 $0.02B $0.01B 2.41
2008-09-30 $0.02B $0.01B 2.59
2008-06-30 $0.01B $0.01B 1.10
2008-03-31 $0.01B $0.01B 1.27
2007-12-31 $0.01B $0.01B 1.52
2007-09-30 $0.02B $0.01B 3.53
2007-06-30 $0.03B $0.01B 4.88
2007-03-31 $0.03B $0.01B 4.27
2006-12-31 $0.01B $0.01B 2.12
2006-09-30 $0.02B $0.01B 3.41
2006-06-30 $0.01B $0.01B 2.05
2006-03-31 $0.02B $0.01B 3.13
2005-12-31 $0.02B $0.01B 2.48
2005-09-30 $0.01B $0.01B 2.46
2005-06-30 $0.02B $0.00B 5.13
2005-03-31 $0.01B $0.00B 3.43
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.011B $0.007B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.499B 41.70
Takeda Pharmaceutical (TAK) Japan $56.434B 10.53
Astellas Pharma (ALPMY) Japan $29.621B 18.50
Merck (MKGAF) Germany $23.632B 0.00
Eisai (ESALY) Japan $21.928B 19.11
UCB SA (UCBJF) Belgium $20.583B 0.00
Catalent (CTLT) United States $18.980B 56.77
Grifols, S.A (GRFS) Spain $13.167B 15.08
Neurocrine Biosciences (NBIX) United States $10.211B 80.36
Jazz Pharmaceuticals (JAZZ) Ireland $9.238B 14.92
Ionis Pharmaceuticals (IONS) United States $8.578B 84.04
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.578B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $8.514B 0.00
United Therapeutics (UTHR) United States $7.433B 15.82
IPSEN SA ADR (IPSEY) France $7.040B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.835B 395.56
Sage Therapeutics (SAGE) United States $5.036B 0.00
PTC Therapeutics (PTCT) United States $4.689B 0.00
ChemoCentryx (CCXI) United States $4.387B 0.00
Hypermarcas (HYPMY) Brazil $4.320B 15.86
Cronos Group (CRON) Canada $4.006B 0.00
FibroGen (FGEN) United States $3.919B 0.00
Pacira BioSciences (PCRX) United States $3.352B 72.79
Corcept Therapeutics (CORT) United States $3.209B 31.03
Nektar Therapeutics (NKTR) United States $3.193B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.891B 14.76
Xencor (XNCR) United States $2.841B 0.00
Revolution Medicines (RVMD) United States $2.657B 0.00
Tilray (TLRY) Canada $2.478B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.830B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.814B 15.52
Translate Bio (TBIO) United States $1.736B 0.00
Heron Therapeutics (HRTX) United States $1.666B 0.00
USANA Health Sciences (USNA) United States $1.665B 14.66
Endo (ENDP) Ireland $1.663B 2.52
Ocular Therapeutix (OCUL) United States $1.626B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.517B 0.00
Trillium Therapeutics (TRIL) Canada $1.511B 0.00
ImmunoGen (IMGN) United States $1.476B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.454B 10.10
Theravance Biopharma (TBPH) Cayman Islands $1.153B 0.00
Karyopharm Therapeutics (KPTI) United States $1.128B 0.00
Zogenix (ZGNX) United States $1.056B 0.00
Radius Health (RDUS) United States $1.049B 0.00
Indivior (INVVY) United States $1.046B 0.00
ORGANOGENESIS (ORGO) United States $1.023B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.971B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
VAXART, INC (VXRT) United States $0.804B 0.00
Collegium Pharmaceutical (COLL) United States $0.771B 45.49
Acutus Medical (AFIB) United States $0.760B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.746B 0.00
Esperion Therapeutics (ESPR) United States $0.746B 0.00
Chinook Therapeutics (KDNY) United States $0.665B 0.00
Aerie Pharmaceuticals (AERI) United States $0.661B 0.00
Flexion Therapeutics (FLXN) United States $0.646B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.644B 0.00
Ardelyx (ARDX) United States $0.625B 0.00
Siga Technologies (SIGA) United States $0.573B 16.09
Molecular Templates (MTEM) United States $0.554B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.553B 0.00
Harpoon Therapeutics (HARP) United States $0.542B 0.00
Sundial Growers (SNDL) Canada $0.488B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.487B 0.00
PROFOUND MEDICL (PROF) Canada $0.480B 0.00
Akebia Therapeutics (AKBA) United States $0.458B 0.00
Altimmune (ALT) United States $0.449B 0.00
Summit Therapeutics (SMMT) United States $0.437B 0.00
TherapeuticsMD (TXMD) United States $0.432B 0.00
DURECT (DRRX) United States $0.429B 0.00
CASI Pharmaceuticals (CASI) United States $0.413B 0.00
Rafael Holdings (RFL) United States $0.410B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.385B 0.00
Concert Pharmaceuticals (CNCE) United States $0.379B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.366B 9.54
Matinas Biopharma Holdings (MTNB) United States $0.333B 0.00
Alpine Immune Sciences (ALPN) United States $0.331B 0.00
MEI Pharma (MEIP) United States $0.323B 0.00
Jounce Therapeutics (JNCE) United States $0.309B 0.00
KalVista Pharmaceuticals (KALV) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.297B 19.10
Lannett Co Inc (LCI) United States $0.286B 7.54
Xeris Pharmaceuticals (XERS) United States $0.281B 0.00
Menlo Therapeutics (VYNE) United States $0.277B 0.00
Redhill Biopharma (RDHL) Israel $0.276B 0.00
Otonomy (OTIC) United States $0.275B 0.00
Jaguar Animal Health (JAGX) United States $0.268B 0.00
Aclaris Therapeutics (ACRS) United States $0.262B 0.00
Calithera Biosciences (CALA) United States $0.258B 0.00
CTI BioPharma (CTIC) United States $0.248B 0.00
IMV INC (IMV) Canada $0.231B 0.00
Oncternal Therapeutics (ONCT) United States $0.222B 0.00
OptiNose (OPTN) United States $0.221B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.209B 0.00
Infinity Pharmaceuticals (INFI) United States $0.189B 0.00
Aquestive Therapeutics (AQST) United States $0.186B 0.00
ProPhase Labs (PRPH) United States $0.186B 0.00
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.168B 0.00
IsoRay (ISR) United States $0.167B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.166B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.157B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.155B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
Onconova Therapeutics (ONTX) United States $0.148B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Heat Biologics (HTBX) United States $0.142B 0.00
Novan (NOVN) United States $0.142B 0.00
MediWound (MDWD) Israel $0.137B 0.00
Lipocine (LPCN) United States $0.108B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.097B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.090B 0.00
SCYNEXIS (SCYX) United States $0.087B 0.00
Natural Alternatives (NAII) United States $0.083B 160.00
Hemispherx BioPharma (AIM) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.078B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.073B 0.00
AgeX Therapeutics (AGE) United States $0.073B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.073B 0.00
Biomerica (BMRA) United States $0.071B 0.00
Recro Pharma (REPH) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
India Globalization Capital (IGC) United States $0.066B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
Vical (BBI) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.059B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 25.00
PolarityTE (PTE) United States $0.047B 0.00
Regulus Therapeutics (RGLS) United States $0.047B 0.00
Neos Therapeutics (NEOS) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.59
NovaBay Pharmaceuticals (NBY) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
Flex Pharma (SLRX) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
HANCOCK JAFFE (HJLI) United States $0.020B 0.00
Cyanotech (CYAN) United States $0.020B 32.31
Bellicum Pharmaceuticals (BLCM) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00